4//SEC Filing
Flynn Paul R 4
Accession 0001093557-23-000104
CIK 0001093557other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 4:36 PM ET
Size
5.2 KB
Accession
0001093557-23-000104
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Flynn Paul R
EVP, Global Revenue
Transactions
- Sale
Common Stock
2023-04-17$120.00/sh−2,781$333,720→ 52,112 total
Footnotes (2)
- [F1]On September 9, 2022, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- [F2]Included in this number are 52,112 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001850141
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 4:36 PM ET
- Size
- 5.2 KB